Created with Sketch.
15 minutes | Sep 30, 2021
An interview with Claudia Trenkwalder, MDS President
Dr. Schaefer discusses with Dr. Trenkwalder the 2021 Virtual MDS Congress, her tenure as the MDS president, and her hopes for the future of the MDS.
14 minutes | Sep 1, 2021
Blinded RT-QuIC analysis of alpha-synuclein biomarker in skin tissue from Parkinson's disease patients
Dr. Schaefer speaks with Dr. Kanthasamy about RT-QuIC from skin tissues as a potential new biomarker for Parkinson's disease.
22 minutes | Aug 1, 2021
Dr. Schaefer speaks with Dr. Olvera about trending videos of tics and other neurological syndromes on social media.
17 minutes | Jun 1, 2021
Cognitive and visuospatial abilities in dystonia
Dr. Schaefer speaks with Dr. Camargo about the non-motor and prodromal features of dystonia.
16 minutes | May 1, 2021
Autophagy in Levodopa-Induced Dyskinesia. A new potential therapeutic target
Dr. Matarazzo interviews Prof. Fisone about the role of autophagy in Levodopa-Induced Dyskinesia.
18 minutes | Apr 1, 2021
Electroconvulsive therapy in movement disorders
Dr. Schaefer discusses with Dr. Garcia Ruiz his recent paper in Movement Disorders Clinical Practice discussing the history and data behind the use of electroconvulsive therapy in Parkinson's disease and other movement disorders.
14 minutes | Mar 1, 2021
Acetylcholine Nuclei Atrophy Predicts Gait Changes in Parkinson's Disease
Dr. Matarazzo interviews Dr. Ray on a recently published article that demonstrates a relationship between changes in cholinergic nuclei in MRI and future gait disorders in Parkinson's disease.
18 minutes | Feb 1, 2021
Parkinsonian syndromes and Parkinson's subtypes: Will a single neuroimaging modality ever be enough?
Dr. Schaefer speaks with Dr. Pavese about the imaging modalities currently in use and emerging to differentiate parkinsonian syndromes and Parkinson's subtypes, and how imaging helps us to understand, study, and treat these conditions.
9 minutes | Feb 1, 2021
Anxiety in Parkinson's disease and its correlates in MRI-based functional connectivity
Dr. Matarazzo interviews Dr. De Micco on the functional MRI correlates of anxiety in Parkinson's disease, highlighting the main results of the article she recently published on the topic in the Movement Disorders Journal.
8 minutes | Jan 9, 2021
Scar Dancing Syndrome
Dr. Wu discusses a newly-described peripherally-induced movement disorder (PIMD), and discusses with Dr. Schaefer the potential pathophysiologies of PIMDs.
8 minutes | Jan 4, 2021
Neuroinflammation in Parkinson's Disease, where are we now?
Dr. Matarazzo interviews Dr. Standaert about the review article he recently published on neuroinflammation in Parkinson's disease, including the main evidence of its role on the pathogenesis of the disease and how understanding it better may help us discovering new therapeutic targets.
12 minutes | Nov 20, 2020
Neurofilament light chain in Parkinson's disease
Dr. Brit Mollenhauer discusses the recent advances in the use of neurofilament light chain for the diagnosis and follow up of Parkinson's disease and related disorders, highlighting the results of a recent longitudinal study.
11 minutes | Nov 8, 2020
Anti-inflammatory drugs use impacts the risk of developing PD in LRRK2 mutation carriers | 2020 | September
Dr. Marta San Luciano shares the main findings of the recently published article on the impact of non-steroidal anti-inflammatory drugs use on the risk of developing PD in a large LRRK2 mutation carriers cohort.
12 minutes | Oct 13, 2020
2020 Research Article Award from the Movement Disorders Journal | Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson's Disease
Dr. Michele Matarazzo interviews Dr. Amy Amara, the first author of the article awarded as "2020 Research Article from Movement Disorders" on the effects of exercise on sleep in Parkinson's disease. Link to the article: https://doi.org/10.1002/mds.28009
11 minutes | Oct 13, 2020
2020 Review Article Award from the Movement Disorders Journal - Value of invivosynuclein deposits in Parkinsons disease - Asystematic review and metaanalysis
Dr. Michele Matarazzo interviews Dr. Kazuto Tsukita, the first author of the article awarded as "2020 Review Article from Movement Disorders" on the advances of in-vivo alpha-synuclein detection as a biomarker for Parkinson. Link to the article: https://doi.org/10.1002/mds.27794
17 minutes | Sep 21, 2020
Deep Brain Stimulation for Parkinson, beyond motor improvement: Social and Occupational outcomes
In this interview, Prof. Deuschl highlights the main results of the EARLYSTIM project, focusing on non-motor outcomes, and especially on the effects of DBS on Social and Occupational Functioning in Parkinson's Disease.
13 minutes | Jul 7, 2020
Late-stage parkinsonism, do we know enough?
Dr. Matarazzo interviews Dr. Anette Schrag about the recently published article on late-stage parkinsonism and related neuropsychiatric complications. Why is it important? And are we doing enough to help patients at this stage?
17 minutes | May 25, 2020
Movement Disorders in times of COVID-19: Practicing medicine in time of pandemic and future of movement disorders medical practice
Dr. Matarazzo interviews Prof. Roy Alcalay on the effects that the COVID-19 pandemic is having on the clinical activity and how it is changing the way we see patients. Will telemedicine be an integrating part of our clinical practice?
14 minutes | May 25, 2020
Movement Disorders in times of COVID-19: interview with the president on the MDS activities during the COVID crisis
In this interview the president of the MDS, Prof Claudia Trenkwalder shares the main changes and strategies that the MDS is implementing to adapt to the COVID-19 pandemic, including the replacement of the International MDS congress with a virtual meeting.
24 minutes | May 17, 2020
Movement Disorders in times of COVID-19: How to manage Parkinson's disease and related disorders and is there a link between COVID and PD?
Dr. Matarazzo interviews Prof. Angelo Antonini on the effect of the COVID-19 pandemic on Parkinson's disease and other movement disorders patients and how to manage them. And also, what is the evidence of a link between COVID-19 and Parkinson's disease?
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2021